Sanofi-Aventis Biotech Company Profile

13:09 EDT 19th September 2018 | BioPortfolio

Just like scientists working in industry, universities and research institutions, students are required to submit a project outline describing their proposed research to a scientific evaluation committee. Students whose projects are approved may receive up to $200 in funding to help pay for equipment, supplies and other costs. For approved projects, the proposal evaluation committee will attempt to suggest the name(s) of potential mentors from the local biotechnology who may be able to provide students with access to research materials, expert advice and some of the supplies and equipment required to carry out their projects. In some, but not all regions, there are two different categories for students - Open Competition (grades 9 to 12) and Junior Competition (grades 7 & 8)


B&D Consulting 805 15th Street, NWSuite 700
District of Columbia
United States of America


Phone: 202.312.7400
Fax: 202.312.7460
Email: .,

News Articles [2524 Associated News Articles listed on BioPortfolio]

#jobs #lifescience Sanofi-Aventis: Director, Global Regulatory Team Lead

Biotechnology, Pharma and Biopharma News – Research – Science – Lifescience ://Biotech-Biopharma-Pharma: Sanofi-Aventis: Director, Global Regulatory Team Lead . Competitive Salary: S...

sanofi-aventis’ New Direction

Since Chris Viehbacher joined sanofi-aventis as CEO his aim has been to get the company recognised as a global healthcare company and not solely as a producer of vaccines. Jean-Claude Muller, Senior V...

Epistem announces collaboration with Sanofi Aventis

Epistem plc, the UK biotechnology and personalised medicine company today announced a collaboration with sanofi-aventis U.S. Inc. relating to the use of Epistem's proprietary biomarker gene expression...

The Transformation Of Sanofi-Aventis U.S.

The exclusive Life Science Leader interview with Gregory Irace, president and CEO of sanofi-aventis U.S. By Dan Schell, Life Science Leader magazine

Royalties under patent licence agreements: can they remain payable even if the licensed patents(s) are revoked or not practised? Lessons from Genentech Inc v Hoechst GmbH & Sanofi-Aventis Deutschland GmbH

Précis In its recent decision in Genentech Inc v Hoechst GmbH & Sanofi-Aventis Deutschland GmbH (7 July 2016), the Court of Justice of the EU (“CJEU”) has ruled that an obligati...

Deutsche Bank senkt Ziel für Sanofi auf 87 Euro - 'Buy'

Die Deutsche Bank hat das Kursziel für Sanofi von 88 auf 87 Euro gesenkt, aber die Einstufung auf "Buy" belassen. Der Zusammenschluss von Sanofi und Aventis habe in den vergangenen zehn Jahren krä.....

Dyadic International Announces Research Collaboration with Sanofi-Aventis

JUPITER, Fla., Sept. 07, 2018 (GLOBE NEWSWIRE) -- Dyadic International, Inc. (“Dyadic”) (OTCQX: DYAI), a global biotechnology company focused on further improving and applying its proprietary C...

The Future

The Future Paul Larsmon reviews a series of interviews with some of Pharma and Biotech’s biggest players, including Doug Giordano from Pfizer, Dan Zabrowski from Roche and Jean-Claude Muller from S...

PubMed Articles [34 Associated PubMed Articles listed on BioPortfolio]

Letter--Incorporating Real-World Evidence and Patient Value Criteria into Value-Based Frameworks for Relapsed/Refractory Multiple Myeloma.

Orlowski has received research funding from Amgen, BioTheryX, Bristol-Myers Squibb, Celgene Corporation, and Takeda Pharmaceuticals; honoraria from Amgen, Bristol-Myers Squibb, Celgene Corporation, Ja...

Intravitreal Ziv-Aflibercept for Diabetic Macular Edema: 48-Week Outcomes.

To study the safety and efficacy of intravitreal injections of ziv-aflibercept (IVI-ZA) (Zaltrap; Sanofi-Aventis and Regeneron Pharmaceuticals, Tarrytown, NY) during a period of 48 weeks in patients w...

Second-quarter biotech job picture.

Public biotech in 2017-the numbers.

Gates unveils biotech-within-a-charity.

Clinical Trials [111 Associated Clinical Trials listed on BioPortfolio]

A Bioequivalence Study Comparing Camoquin® Suspension (Pfizer) To Flavoquine® Tablets (Sanofi Aventis) In Healthy Subjects

The purpose of this study is to determine bioequivalence of amodiaquine suspension ( Pfizer) and the WHO approved reference product Flavoquine® tablet ( Sanofi Aventis).

Assessment of Cardioversion Using Transesophageal Echocardiography II (ACUTE II)

SPECIFIC AIM: To test the safety and feasibility of using low molecular weight heparin (LMWH, enoxaparin sodium; Lovenox, Sanofi-Aventis) in lieu of unfractionated heparin (UFH) as antith...

: Pharmacokinetics of Enoxaparin After Coronary Artery Bypass Graft Surgery

To evaluate the pharmacokinetics of the thromboprophylactic agent enoxaparin in postoperative cardiac surgery patients by comparing plasma anti-Xa activity when enoxaparin is administered ...

A Study Comparing the Bioequivalence of Triamcinolone Acetonide Aqueous Nasal Spray (Apotex, Inc.) to That of Nasacort® AQ Nasal Spray (Sanofi-Aventis Pharmaceutical Products, Inc.) In the Treatment of Seasonal Allergic Rhinitis

A randomized, double-blind, placebo-controlled parallel-group study, comparing the bioequivalence of triamcinolone acetonide aqueous nasal spray (Apotex, Inc.) to that of Nasacort® AQ nas...

A Non-inferiority Study With Two Treatment Arms Eszopiclone 3 mg Versus Zopiclone 7.5 mg - for the Treatment of Insomnia

The primary objective of the study is to determine whether eszopiclone (Eurofarma) is non-inferior to the reference drug zopiclone (Imovane®, Sanofi-Aventis) in the treatment of insomnia.

Companies [990 Associated Companies listed on BioPortfolio]

sanofi-aventis U.S.

Sanofi-aventis U.S. is an affiliate of sanofi-aventis, a leading global pharmaceutical company that discovers, develops and distributes therapeutic solutions to help improve the lives of patients. San...

Bristol-Myers Squibb & Sanofi-aventis

Sanofi-aventis U.S. is an affiliate of sanofi-aventis, a leading global pharmaceutical company that discovers, develops and distributes therapeutic solutions to help improve the l...

Sanofi Aventis Groupe

Sanofi-aventis, a leading global pharmaceutical company, discovers, develops and distributes therapeutic solutions to improve the lives of everyone. Sanofi-aventis is listed in Paris (EURONEXT: SA...

Merck and sanofi-aventis

Sanofi-aventis, a leading global pharmaceutical company, discovers, develops and distributes therapeutic solutions to improve the lives of everyone. Sanofi-aventis is listed in Pa...

Sanofi SA

Sanofi S.A. is a French multinational pharmaceutical company headquartered in Paris, France, the world's fourth-largest by prescription sales.

More Information about "Sanofi-Aventis Biotech" on BioPortfolio

We have published hundreds of Sanofi-Aventis Biotech news stories on BioPortfolio along with dozens of Sanofi-Aventis Biotech Clinical Trials and PubMed Articles about Sanofi-Aventis Biotech for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Sanofi-Aventis Biotech Companies in our database. You can also find out about relevant Sanofi-Aventis Biotech Drugs and Medications on this site too.

Quick Search


Relevant Topic

Biotechnology - Biotech
"using living things to create products or to do tasks for humans" About Biotechnology - Biotech Biotechnology is the practice of using plants, animals and micro-organisms such as bacteria, as well as biological processes - such as the ripen...

Corporate Database Quicklinks

Searches Linking to this Company Record